Delivery Order SPE2DB22D2006-SPE2DB25FV8DC
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,093.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567461849 ! VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of March 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $35,270.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of VYVANSE CAPS 40MG, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,783.36 firm fixed-price delivery order is for the supply of 4566343823 - VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through November 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds an Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,485.36 delivery order contract is for the supply of VYVANSE 40 MG CAPSULE 100S, with an ultimate completion date of October 18, 2024. The contract has a firm fixed price pricing type and does not utilize any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,556.68, is a delivery order for 4560404700 - VYVANSE 40 MG CAPSULE 100S. The contract has a firm fixed price pricing type and an ultimate completion date of March 29, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,041.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,783.60, is a Firm Fixed Price Delivery Order for the supply of VYVANSE 40 MG CAPSULE 100S to the DLA. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $2,984.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of February 23, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,278.90 firm-fixed-price delivery order is for the supply of 4564441539 VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,783.60, is a Firm Fixed Price Delivery Order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen is the prime contractor and there is no indication of any set-aside designation for this...